Crigler–Najjar syndrome: therapeutic options and consequences of mutations in the UGT1A1 complex
- 1 November 2008
- journal article
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 3 (6) , 725-737
Abstract
Crigler-Najjar syndrome (CN), a rare inherited disorder characterized by failure of bilirubin glucuronidation, can lead to severe disability and death from kernicterus. Gilbert syndrome is a more common, benign familial unconjugated hyperbilirubinemia. The underlying problem in both conditions is impaired bilirubin conjugation and elimination due to a mutation in uridine 5'-diphosphate glucuronyltransferase. The mainstay of current management of CN is phototherapy, followed by liver transplantation. Here, we review other therapies, including hepatocyte transplantation, that have been successfully used to lessen the phenotype, although long-term engraftment of cells remains elusive. Gene therapy holds hope for the future whereby the patient's hepatocytes are transduced with the wild-type gene. Outstanding issues include safety of the gene vector and establishing immunotolerance to both vector and the new protein. The significant advances in understanding the relevance of mutations in UGT not only in glucuronidation of bilirubin, but other drugs and substances, are also reviewed.Keywords
This publication has 108 references indexed in Scilit:
- Human hepatic stem cells from fetal and postnatal donorsJournal of Experimental Medicine, 2007
- Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn ratGut, 2007
- In vitro–in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promisesBiochemical Pharmacology, 2006
- Hepatocyte transplantation for liver‐based metabolic disordersJournal of Inherited Metabolic Disease, 2006
- Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal PeriodJournal of Biological Chemistry, 1996
- Long-term effects of intrasplenically transplanted adult hepatocytes and fetal liver in hyperbilirubinemic Gunn ratsTransplant International, 1995
- Identification of Defect in the Genes for Bilirubin UDP-Glucuronosyltransferase in a Patient with Crigler-Najjar Syndrome Type IIBiochemical and Biophysical Research Communications, 1993
- Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1The Lancet, 1993
- Quantitation of transplanted hepatic mass necessary to cure the gunn rat model of hyperbilirubinemiaJournal of Pediatric Surgery, 1992
- The enterohepatic shunting of bilirubin in the newborn infant: I. Use of oral activated charcoal to reduce normal serum bilirubin valuesThe Journal of Pediatrics, 1964